MissionIR Articles
-
MissionIRNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Announces Underwriters Exercise of Overallotment Option
Trxade Group, Inc. (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform that enables price transparency and increased profit margins to healthcare buyers and sellers of pharmaceuticals, today announced the exercise by the underwriters…
-
Trxade Group Inc. (NASDAQ: MEDS) Uplists to Nasdaq, Expects Gross Proceeds of $5.2M from Common Stock Sale
Trxade announces pricing of a firm commitment public offering of 806,452 shares of its common stock Proceeds to be used as working capital and to fund future acquisitions Company’s B2B online purchasing platform currently has…
-
MissionIRNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Closes Firm Commitment Common Stock Offering
Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform that enables price transparency and increased profit margins to healthcare buyers and sellers of pharmaceuticals, on Tuesday announced the closing of its underwritten…
Search Articles
Latest Articles
- MissionIRNewsBreaks – Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Marks Pivotal Moment on Path to 2026 Rare Earth Oxide Production
- PowerBank Corporation (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: 103) Marks Bold Entry Into the Growing Battery Storage Market with 4.99 MW BESS in Ontario
- Soligenix Inc. (NASDAQ: SNGX) Working to Advance Heat-Stable Ricin Vaccine with Promising Efficacy
- New Pacific Metals Corp. (NYSE American: NEWP) (TSX: NUAG) Eyes Bolivia’s Untapped Silver Potential Amid Global Supply Gaps
- MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reports Q2 2025 Results, Advances TPI 287 Toward Phase 2 GBM Trial